Back to Journals » OncoTargets and Therapy » Volume 13

A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report

Total article views   HTML views PDF downloads Totals
4,194 Dovepress* 3,808+ 788 4,596
PubMed Central* 386 147 533
Totals 4,194 935 5,129
*Since 2 November 2020

View citations on PubMed Central and Google Scholar